Pan Pharmaceuticals action settled

We successfully defended five Commonwealth public servants who were sued in their personal capacities in a $150 million class action in the Federal Court. It was alleged the officers were misfeasant in their role in the largest therapeutic goods recall in Australia’s history, which triggered the collapse of a large pharmaceutical company, Pan Pharmaceuticals.


Related Articles

INSURERS WIN ON AGGREGATION CLAUSE IN COVERAGE DISPUTE OVER CLASS ACTION

Legal Directions

Bank of Queensland Ltd v AIG Australia Ltd [2018] NSWSC 1689 Clients of a financial planner had been defrauded in a…

Continue reading

CLASS ACTION FORGES AHEAD AGAINST INSURERS (IN PLACE OF THE INSURED)

Legal Directions

In its recent decision in Rushleigh Services Pty Ltd v Forge Group Limited (In Liquidation) (Receivers and Managers Appointed) [2018] FCA…

Continue reading

D&O INSURANCE IMPLICATIONS ARISING FROM COVID-19

Legal Directions

Introduction The coronavirus (COVID-19) outbreak has caused an unprecedented crisis in a very short period of time. Like every other sector…

Continue reading